Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Dietary isoflavones may protect against prostate cancer in Japanese men.

Nagata Y, Sonoda T, Mori M, Miyanaga N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, Takahashi A, Tsukamoto T, Akaza H.

J Nutr. 2007 Aug;137(8):1974-9.

PMID:
17634273
2.

Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.

Nagata Y, Sugiyama Y, Fukuta F, Takayanagi A, Masumori N, Tsukamoto T, Akasaka H, Ohnishi H, Saitoh S, Miura T, Moriyama K, Tsuji H, Akaza H, Mori M.

Int Urol Nephrol. 2016 Sep;48(9):1453-60. doi: 10.1007/s11255-016-1335-7. Epub 2016 Jun 4.

PMID:
27262851
3.

Soy and isoflavone consumption in relation to prostate cancer risk in China.

Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):665-8.

4.

Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.

Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S; Japan Public Health Center-Based Prospective Study Group.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):538-45. Epub 2007 Mar 2.

5.
6.

Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.

Budhathoki S, Joshi AM, Ohnaka K, Yin G, Toyomura K, Kono S, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R.

Scand J Gastroenterol. 2011 Feb;46(2):165-72. doi: 10.3109/00365521.2010.522720. Epub 2010 Oct 24.

PMID:
20969489
7.

Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men.

Sonoda T, Suzuki H, Mori M, Tsukamoto T, Yokomizo A, Naito S, Fujimoto K, Hirao Y, Miyanaga N, Akaza H.

Eur J Cancer Prev. 2010 Mar;19(2):131-7. doi: 10.1097/CEJ.0b013e328333fbe2.

PMID:
19952760
8.

Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.

Kurahashi N, Iwasaki M, Inoue M, Sasazuki S, Tsugane S.

J Clin Oncol. 2008 Dec 20;26(36):5923-9. doi: 10.1200/JCO.2008.16.8807. Epub 2008 Nov 17.

PMID:
19018085
9.

Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.

Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola J Jr, Laginha FM, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Kobayashi M, Ishihara J, Yamamoto S, Hanaoka T, Tsugane S.

Breast Cancer Res Treat. 2009 Jul;116(2):401-11. doi: 10.1007/s10549-008-0168-1. Epub 2008 Sep 6.

PMID:
18777206
10.

Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.

Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, Yamamoto S, Tsugane S; Japan Public Health Center-based prospective study group.

J Clin Oncol. 2008 Apr 1;26(10):1677-83. doi: 10.1200/JCO.2007.13.9964. Epub 2008 Mar 3.

PMID:
18316793
11.

Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women.

Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Noda M, Tsugane S.

J Nutr. 2010 Mar;140(3):580-6. doi: 10.3945/jn.109.116020. Epub 2010 Jan 6.

PMID:
20053935
12.

Blood isoflavone levels during intake of a controlled hospital diet.

Takashima N, Miyanaga N, Komiya K, More M, Akaza H.

J Nutr Sci Vitaminol (Tokyo). 2004 Aug;50(4):246-52.

PMID:
15527065
13.

S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Virk-Baker MK, Barnes S, Krontiras H, Nagy TR.

Nutr Res. 2014 Feb;34(2):116-25. doi: 10.1016/j.nutres.2013.12.002. Epub 2013 Dec 18.

14.

Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians.

Iwasaki M, Hamada GS, Nishimoto IN, Netto MM, Motola J Jr, Laginha FM, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Kobayashi M, Ishihara J, Yamamoto S, Hanaoka T, Tsugane S.

Cancer Sci. 2009 May;100(5):927-33. doi: 10.1111/j.1349-7006.2009.01118.x. Epub 2009 Feb 26.

15.

Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.

Wu AH, Yu MC, Tseng CC, Twaddle NC, Doerge DR.

Carcinogenesis. 2004 Jan;25(1):77-81. Epub 2003 Oct 10.

PMID:
14555615
16.

Soy, isoflavones, and prevalence of allergic rhinitis in Japanese women: the Osaka Maternal and Child Health Study.

Miyake Y, Sasaki S, Ohya Y, Miyamoto S, Matsunaga I, Yoshida T, Hirota Y, Oda H.

J Allergy Clin Immunol. 2005 Jun;115(6):1176-83.

PMID:
15940131
17.

Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study.

Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S; Japan Public Health Center-Based Prospective Study Group.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2128-35. doi: 10.1158/1055-9965.EPI-08-0182.

18.

Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study.

Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN; Multiethnic Cohort Study.

Int J Cancer. 2008 Aug 15;123(4):927-32. doi: 10.1002/ijc.23594.

19.

Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women.

Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane S; JPHC Study Group.

Int J Cancer. 2009 Apr 1;124(7):1644-9. doi: 10.1002/ijc.24121.

20.

Assessment of dietary isoflavone intake among middle-aged Chinese men.

Lee SA, Wen W, Xiang YB, Barnes S, Liu D, Cai Q, Zheng W, Shu XO.

J Nutr. 2007 Apr;137(4):1011-6.

Supplemental Content

Support Center